Cough medicine Ambroxal shows potential to slow Parkinson’s-related dementia

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol—a cough medicine used safely for decades in Europe—can slow dementia in people with Parkinson’s disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup